Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2007
10/16/2007US7282565 PRO362 polypeptides
10/16/2007US7282564 RNA interference pathway genes as tools for targeted genetic interference
10/16/2007US7282561 PRO16090 polypeptides
10/16/2007US7282560 PRO 4326 polypeptides
10/16/2007US7282559 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2007US7282558 PRO4329 polypeptide
10/16/2007US7282557 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
10/16/2007US7282351 Prostatic growth factor
10/16/2007US7282342 Detecting tripeptide glycyl-L-prolyl-L-glutamic acid (gly-pro-glu; GPE antibodies derivatized with keyhole limpet hemocyanin, diethyl carbodiimide, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, or sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate
10/16/2007US7282341 Method for early detection during the clinical phase of the infection, reliable, rapid, inexpensive, making it possible to adapt the medical care in time
10/16/2007US7282205 Anti-hepatitis A virus antibodies
10/16/2007US7282204 modulating tumor growth by contacting a tumor cell with an agonist or antagonist of IL-23, particularly a binding mixture of IL-23R or nucleotide coding it comprising: an antigen-binding site of an antibody; an extracellular region of IL-23R; a small molecule; and an anti-sense nucleic acid or siRNA
10/16/2007US7282203 Use of NOTCH pathway interfering agents for treatment of plasma cell disorders
10/16/2007US7282198 Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
10/16/2007CA2491918C Methods for detecting or assaying virus
10/16/2007CA2155793C Monoclonal antibiodies for selective immunological determination of high molecular weight, intact laminin forms in body fluids
10/16/2007CA2124126C Monoclonal antibodies and fv specific for cd2 antigen
10/11/2007WO2007115157A2 Pto selector mechanism for parallel axis transmission
10/11/2007WO2007115066A2 Facilitating application synchronization with a reservation protocol at a sender without application receiver participation
10/11/2007WO2007115056A2 Wireless repeater with universal server base and modular donor antenna options
10/11/2007WO2007114861A2 Il-21 receptor antagonists
10/11/2007WO2007114634A1 Monoclonal specific to human neural precursor cell and its use
10/11/2007WO2007114550A1 A novel monoclonal antibody specific to the l1cam, a hybridoma producing the same and a method producing the same
10/11/2007WO2007114496A1 Novel anti-cd98 antibody
10/11/2007WO2007114340A1 Pseudomonas aeruginosa outer membrane protein pa0427
10/11/2007WO2007114337A1 Immune agglutination reaction reagent kit and method of assaying antigen
10/11/2007WO2007114325A1 Antibody modification method for purifying bispecific antibody
10/11/2007WO2007114319A1 Method for control of blood kinetics of antibody
10/11/2007WO2007113648A2 Ctla4 antibody combination therapy
10/11/2007WO2007113172A2 Antibodies against amyloid-beta peptide
10/11/2007WO2007112927A1 Method for the detection and/or enrichment of analyte proteins and/or analyte peptides from a complex protein mixture
10/11/2007WO2007096396A3 Methods for treating autoimmune or demyelinating diseases
10/11/2007WO2007085567A3 Synergistic compositions for treating hiv
10/11/2007WO2007085470A3 Cd19-specific immunotoxin and treatment method
10/11/2007WO2007030642A3 Toxin conjugated eph receptor antibodies
10/11/2007WO2006124451A3 Anti-il-13 antibodies, compositions, methods and uses
10/11/2007WO2006109071A8 Vaccine against burkholderia infections
10/11/2007WO2006108627A9 Anti-egfr antibody therapy based on an increased copy number of the egfr gene in tumor tissues
10/11/2007WO2006096392A3 Enzymes involved in astaxanthin, carotenoid and isoprenoid biosynthetic pathways, genes encoding them and methods of making and using them
10/11/2007WO2004007527A3 Secreted proteins
10/11/2007US20070238869 Nucleotide sequences coding heavy chain of immunoglobulin specific for human tissue factor for use in prevention and treatment of thrombosis
10/11/2007US20070238863 Incubating labeled monoclonal antibody with sample to excyst oocytes; presence of viable parasite detected by binding
10/11/2007US20070238862 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
10/11/2007US20070238859 Wound healing agents; anticancer agents; cardiovascular disorders
10/11/2007US20070238665 Modified immunoglobulin fragment for use in diagnosis, prevention and treatment of cancer, inflammation and cardiovascular disease; immunotherapy; immunodiagnostics
10/11/2007US20070238664 70 Human Secreted Proteins
10/11/2007US20070238653 Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
10/11/2007US20070238644 Human Chemokines CKBeta-4 and CKBeta-10/MCP-4
10/11/2007US20070238194 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver and uses thereof
10/11/2007US20070238182 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
10/11/2007US20070238171 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
10/11/2007US20070238150 Pro4356 polypeptides
10/11/2007US20070238136 Assays and peptide substrate for determining aggrecan degrading metallo protease activity
10/11/2007US20070238135 Novel g-protein coupled receptor and dna sequences thereof
10/11/2007US20070238133 Immunoglobulins devoid of light chains
10/11/2007US20070238130 Novel Metalloproteinases
10/11/2007US20070237793 Attenuated or mutated pasteurella for use as tool in developing bactericidal agents; immunotherapy; immunogens for vaccines
10/11/2007US20070237783 HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
10/11/2007US20070237779 Binding constructs and methods for use thereof
10/11/2007US20070237776 Binds to hIL-18R alpha with high affinity and by the ability to neutralize hIL-18 activity, including IL-18-induced interferon gamma expression and IL-18-induced cellular activation; sepsis; cardiovascular disorders; liver injury; arthritis, including rheumatoid arthritis; inflammatory bowel diseases
10/11/2007US20070237775 Anti-Ghrelin Antibodies
10/11/2007US20070237773 Human sema4a protein antibodies and uses thereof
10/11/2007US20070237771 Multicomponent conjugates which bind to target molecules and stimulate T cell lysis
10/11/2007US20070237769 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
10/11/2007US20070237768 Fibroblast growth factor 21 compounds fused to proteins that have the effect of extending the in vivo half-life of the polypeptides; these fusion proteins can be used to treat non-insulin dependent diabetes mellitus, obesity and metabolic syndrome
10/11/2007US20070237767 Fc Variants Having Decreased Affinity for FcyRllla
10/11/2007US20070237766 Fc Variants Having Increased Affinity for FcyRllla
10/11/2007US20070237765 Fc Variants Having Increased Affinity for FcyRl
10/11/2007US20070237764 Binding polypeptides with restricted diversity sequences
10/11/2007US20070237762 Process for Concentration of Antibodies and Therapeutic Products Thereof
10/11/2007US20070237761 Chimeric Anti Cd44 Antibodies and Their Use for Treating Acute Myeloid Leukemia
10/11/2007US20070237760 Detection and treatment of cancer
10/11/2007US20070237759 Antibodies that bind PAR-2
10/11/2007US20070237754 Transient immortalization
10/11/2007US20070237744 Targeted Gene Delivery to Non-Phagocytic Mammalian Cells Via Bacterially Derived Intact Minicells
10/11/2007US20070237713 PCan065 Antibody Compositions and Methods of Use
10/11/2007US20070237712 Methods of Redistributing Apical Target Antigens to Detect and Treat Cellular Proliferative Disease
10/11/2007US20070237711 Method of Increasing Radiation Sensitivity by Inhibition of Beta One Integrin
10/11/2007DE102006015001A1 Verfahren zum Nachweis und/oder zur Anreicherung von Analytproteinen und/oder Analytpeptiden aus einer komplexen Proteinmischung A method for detecting and / or for the enrichment of analyte proteins and / or from a complex protein mixture Analytpeptiden
10/11/2007CA2648618A1 Novel anti-cd98 antibody
10/11/2007CA2647846A1 Method for control of blood kinetics of antibody
10/11/2007CA2647837A1 Use of the .alpha. chain of brain spectrin and fragments thereof, for diagnosing cerebral diseases
10/11/2007CA2647808A1 Antibodies against amyloid-beta peptide
10/11/2007CA2647430A1 Diagnostics and treatments for tumors
10/11/2007CA2647282A1 Ctla4 antibody combination therapy
10/11/2007CA2645904A1 Pseudomonas aeruginosa outer membrane protein pa0427
10/11/2007CA2638821A1 Gene disruptons, compositions and methods relating thereto
10/11/2007CA2632218A1 Il-21 receptor antagonists
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP1842917A1 Sequences of an Ih ion channel and their application
10/10/2007EP1842859A2 Monoclonal antibody specific for beta A4 peptide
10/10/2007EP1842856A2 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/10/2007EP1842065A2 Methods for diagnosis and prognosis of epithelial cancers
10/10/2007EP1841882A1 Protein phosphorylation in egfr-signaling pathways
10/10/2007EP1841796A2 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
10/10/2007EP1841795A1 Cytotoxicity mediation of cells evidencing surface expression of cd63
10/10/2007EP1841794A2 Adam-9 modulators
10/10/2007EP1841793A2 Ovr110 antibody compositions and methods of use
10/10/2007EP1841789A2 Hiv resistance genes
10/10/2007EP1841788A1 Novel snake toxin
1 ... 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 ... 1494